Neuralink receives approval for implantation of second brain implant
The FDA has approved the second implantation procedure for the Neuralink brain device. Following the successful implantation of the device in Noland Arbaugh, Neuralink has received approval for another patient.
Here's What We Know
The founder of Neuralink, Elon Musk, said that the company is accepting applications for participation in clinical trials aimed at studying the possibilities of this technology for patients with various disorders of the central nervous system.
Redefining the boundaries of human capability requires pioneers.
- Neuralink (@neuralink) 16 May 2024
If you have quadriplegia and want to explore new ways of controlling your computer, we invite you to participate in our clinical trial. pic.twitter.com/svqfAkVV1M
Neuralink has also developed a potential solution to the problem that occurred with the Arbo implant when some of the threads came out of the brain. The updated software restored many of the implant's functions, allowing Arbo to play chess, control a music player, and perform other activities.
The company plans to place the implant threads deeper into the brain during the second procedure to prevent them from being pulled out as happened in Arbo's case. The FDA supports these changes, and the company plans to complete the second surgery in June. More than 1,000 people have already signed up for the opportunity to participate in the next clinical trial.
Source: The Wall Street Journal
